Reported impact
Business outcome
Sanofi reports that its AI program is helping shorten time-to-market, improve efficiency, make production more agile and predictive, strengthen supply chain resilience, identify new therapeutic targets, and improve predictive accuracy for personalized medicine.
- Productivity Improvement
- Scalability
- Speed to Market
Solution
Sanofi describes an in-house AI transformation program centered on its Digital Accelerator network, with the newest accelerator focused on Manufacturing & Supply. In this implementation, Sanofi uses Digital twins to run virtual production simulations before or alongside physical operations, helping teams test scenarios and improve production decisions. It also combines AI + Internet of Things (IoT) for real-time monitoring and predictive decision-making across the manufacturing value chain, indicating that operational signals from industrial processes are captured continuously and used by AI-driven models. The company says it is also using scalable platforms to strengthen global supply chain resilience, while related Patient Digital Twin technology improves predictive accuracy for personalized medicine. The page does not name a separate storage platform, external cloud, or serving layer, but it clearly places AI inside production, R&D, and supply workflows rather than treating it as a future aspiration.
Data flow
Operational manufacturing signals and IoT monitoring data are captured from Sanofi's manufacturing value chain, analyzed with AI-driven models, and used inside digital twin simulations and predictive decision workflows. The resulting insights feed manufacturing, supply, and R&D teams so production, resilience, and medicine delivery decisions can be made faster.